These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22536298)

  • 21. CD8 T-cell response to antiretroviral therapy.
    Stricker RB; Goldberg B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):176-7. PubMed ID: 9241121
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects.
    Smith RJ; Wahl LM
    Bull Math Biol; 2005 Jul; 67(4):783-813. PubMed ID: 15893553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A simulation model for HIV infection and its interaction with a cytotoxicimmune response].
    Londoño-González CA; Toro-Zapata HD; Trujillo-Salazar CA
    Rev Salud Publica (Bogota); 2014; 16(1):114-27. PubMed ID: 25184457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fuzzy modeling in symptomatic HIV virus infected population.
    Jafelice RM; de Barros LC; Bassanezi RC; Gomide F
    Bull Math Biol; 2004 Nov; 66(6):1597-620. PubMed ID: 15522347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs versus benefits: best possible and best practical treatment regimens for HIV.
    Krakovska O; Wahl LM
    J Math Biol; 2007 Mar; 54(3):385-406. PubMed ID: 17205357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Fractional Differential Model of HIV-1 Infection of CD4
    Lichae BH; Biazar J; Ayati Z
    Comput Math Methods Med; 2019; 2019():4059549. PubMed ID: 30728851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
    Wodarz D; Nowak MA
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and Long-Term Optimal Control of a Mathematical Model for HIV Infection of CD4+T Cells.
    Croicu AM
    Bull Math Biol; 2015 Nov; 77(11):2035-71. PubMed ID: 26493544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling HIV immune response and validation with clinical data.
    Banks HT; Davidian M; Hu S; Kepler GM; Rosenberg ES
    J Biol Dyn; 2008 Oct; 2(4):357-85. PubMed ID: 19495424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mathematical model for HIV dynamics with multiple infections: implications for immune escape.
    Deng Q; Guo T; Qiu Z; Chen Y
    J Math Biol; 2024 May; 89(1):6. PubMed ID: 38762831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.
    Pinzone MR; Graf E; Lynch L; McLaughlin B; Hecht FM; Connors M; Migueles SA; Hwang WT; Nunnari G; O'Doherty U
    J Virol; 2016 Dec; 90(23):10436-10445. PubMed ID: 27630237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A delay-differential equation model of HIV infection of CD4(+) T-cells.
    Culshaw RV; Ruan S
    Math Biosci; 2000 May; 165(1):27-39. PubMed ID: 10804258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of skewed functionality of HIV-1-specific cytotoxic CD8(+) T cells from primary to early chronic phase of HIV infection.
    Wang W; Qiu C; Qiu C; Wang Y; Zhang X; Xu J
    PLoS One; 2012; 7(9):e44983. PubMed ID: 23028721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune activation and the pathogenesis of HIV disease: implications for therapy.
    Fernandez S; Lim A; French M
    J HIV Ther; 2009 Nov; 14(3):52-6. PubMed ID: 20218239
    [No Abstract]   [Full Text] [Related]  

  • 35.
    Nemeth J; Vongrad V; Metzner KJ; Strouvelle VP; Weber R; Pedrioli P; Aebersold R; Günthard HF; Collins BC
    Mol Cell Proteomics; 2017 Apr; 16(4 suppl 1):S108-S123. PubMed ID: 28223351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor functional immune recovery in aged HIV-1-infected patients following successfully treatment with antiretroviral therapy.
    Kasahara TM; Hygino J; Andrade RM; Monteiro C; Sacramento PM; Andrade AF; Bento CA
    Hum Immunol; 2015 Oct; 76(10):701-10. PubMed ID: 26429325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatial Lymphocyte Dynamics in Lymph Nodes Predicts the Cytotoxic T Cell Frequency Needed for HIV Infection Control.
    Grebennikov D; Bouchnita A; Volpert V; Bessonov N; Meyerhans A; Bocharov G
    Front Immunol; 2019; 10():1213. PubMed ID: 31244829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Target cell limited and immune control models of HIV infection: a comparison.
    De Boer RJ; Perelson AS
    J Theor Biol; 1998 Feb; 190(3):201-14. PubMed ID: 9514649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs.
    Fraser C; Ferguson NM; Ghani AC; Prins JM; Lange JM; Goudsmit J; Anderson RM; de Wolf F
    AIDS; 2000 Apr; 14(6):659-69. PubMed ID: 10807189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of CTL-mediated killing of HIV-infected cells during the non-productive stage of infection.
    Althaus CL; De Boer RJ
    PLoS One; 2011 Feb; 6(2):e16468. PubMed ID: 21326882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.